Actively Recruiting
Outcome of GATT Combined With Goniosynechiolysis in Glaucoma Patients With Secondary Synechial Angle Closure.
Led by Kasr El Aini Hospital · Updated on 2024-06-06
23
Participants Needed
1
Research Sites
69 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the intraocular pressure reduction effect of combined gonioscopy-assisted transluminal trabeculotomy (GATT) with goniosynechialysis in eyes with secondary synechial angle closure glaucoma.
CONDITIONS
Official Title
Outcome of GATT Combined With Goniosynechiolysis in Glaucoma Patients With Secondary Synechial Angle Closure.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with secondary synechial angle closure glaucoma
- Involvement of more than 180 degrees of the iridocorneal angle
- Requires surgery for uncontrolled intraocular pressure despite maximum tolerated therapy
You will not qualify if you...
- Eyes with primary angle closure glaucoma (PACG)
- Eyes with neovascular glaucoma
- Eyes with retinal pathology
- Eyes requiring combined phacoemulsification and GATT
- Eyes with corneal pathology preventing surgery or imaging
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kasralainy Hospitals
Giza, Egypt, 11555
Actively Recruiting
Research Team
R
Rokaya Radwan
CONTACT
F
Fayrouz Aboalazaym
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here